258 related articles for article (PubMed ID: 27663671)
1. Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
Pushko P; Sun X; Tretyakova I; Hidajat R; Pulit-Penaloza JA; Belser JA; Maines TR; Tumpey TM
Vaccine; 2016 Oct; 34(44):5235-5242. PubMed ID: 27663671
[TBL] [Abstract][Full Text] [Related]
2. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
[TBL] [Abstract][Full Text] [Related]
3. Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.
Tretyakova I; Hidajat R; Hamilton G; Horn N; Nickols B; Prather RO; Tumpey TM; Pushko P
Virology; 2016 Jan; 487():163-71. PubMed ID: 26529299
[TBL] [Abstract][Full Text] [Related]
4. Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice.
Kuah LF; Tang LH; Sutton T; Lim JH; Sin WL; Lamirande E; Subbarao K; Lau YF
J Gen Virol; 2017 Feb; 98(2):155-165. PubMed ID: 27983474
[TBL] [Abstract][Full Text] [Related]
5. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development.
Hong JY; Chen TH; Chen YJ; Liu CC; Jan JT; Wu SC
Antiviral Res; 2019 Apr; 164():12-22. PubMed ID: 30738089
[TBL] [Abstract][Full Text] [Related]
6. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
7. Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses.
Tretyakova I; Pearce MB; Florese R; Tumpey TM; Pushko P
Virology; 2013 Jul; 442(1):67-73. PubMed ID: 23618102
[TBL] [Abstract][Full Text] [Related]
8. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
Pushko P; Tretyakova I; Hidajat R; Zsak A; Chrzastek K; Tumpey TM; Kapczynski DR
Virology; 2017 Jan; 501():176-182. PubMed ID: 27936463
[TBL] [Abstract][Full Text] [Related]
9. Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
Smith GE; Sun X; Bai Y; Liu YV; Massare MJ; Pearce MB; Belser JA; Maines TR; Creager HM; Glenn GM; Flyer D; Pushko P; Levine MZ; Tumpey TM
Virology; 2017 Sep; 509():90-97. PubMed ID: 28624679
[TBL] [Abstract][Full Text] [Related]
10. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.
Giles BM; Bissel SJ; Dealmeida DR; Wiley CA; Ross TM
Clin Vaccine Immunol; 2012 Feb; 19(2):128-39. PubMed ID: 22190399
[TBL] [Abstract][Full Text] [Related]
11. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
Kapczynski DR; Tumpey TM; Hidajat R; Zsak A; Chrzastek K; Tretyakova I; Pushko P
Vaccine; 2016 Mar; 34(13):1575-1581. PubMed ID: 26868083
[TBL] [Abstract][Full Text] [Related]
13. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.
Crevar CJ; Carter DM; Lee KY; Ross TM
Hum Vaccin Immunother; 2015; 11(3):572-83. PubMed ID: 25671661
[TBL] [Abstract][Full Text] [Related]
14. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
15. Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection.
Kang HJ; Chu KB; Yoon KW; Eom GD; Mao J; Kim MJ; Lee SH; Moon EK; Quan FS
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216022
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
[TBL] [Abstract][Full Text] [Related]
17. Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.
Pushko P; Tretyakova I; Hidajat R; Sun X; Belser JA; Tumpey TM
Vaccine; 2018 Jul; 36(29):4346-4353. PubMed ID: 29885769
[TBL] [Abstract][Full Text] [Related]
18. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
19. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
Tao P; Luo M; Zhu D; Qu S; Yang Z; Gao M; Guo D; Pan Z
Viral Immunol; 2009 Jul; 22(4):273-81. PubMed ID: 19594398
[TBL] [Abstract][Full Text] [Related]
20. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
